MENU
CRVS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Corvus Pharmaceuticals (CRVS) Ownership - Who owns Corvus Pharmaceuticals?
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
863 Mitten Road
Phone
+1 650 900-4520
Employees
28
Web
https://www.corvuspharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
317.71M
P/E Ratio
N/A
Total Cash
44.21M
Projected Growth
N/A
Total Debt
1.15M
Revenue
N/A
Risk (Beta)
1.48
Dividend Yield
N/A
Total Cash/Share
0.57
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CRVS
Capitalization
318M
P/E Ratio
N/A
Risk (Beta)
1.48
Dividend Yield
N/A
Total Cash
44.2M
Total Cash/Share
0.57
Total Debt
1.15M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
49.3M
P/B Ratio
6.44
Cash Flow
N/A
Earnings
-0.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
4.90
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-31.13M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-83.20
Shares Held By Institutions
214M
Shares Outstanding - Current
77.1M
Total Liabilities
10.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-22.991
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a provider of anticancer immuno-oncology drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
863 Mitten Road
Phone
+1 650 900-4520
Employees
28
Web
https://www.corvuspharma.com